Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)

Molecular Pharmacology

Volumn 38, Issue 2, 1990, Pages 207-213

  Wrighton, S A ^a   Brian, W R ^a   Sari, M A ^a   Iwasaki, M ^a   Guengerich, F P ^a   Raucy, J L ^a   Molowa, D T ^a   Vandenbranden, M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; AFLATOXIN; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; ERYTHROMYCIN; ESTRADIOL; ETHINYLESTRADIOL; GESTODENE; HYDROCORTISONE; LIVER ENZYME; NIFEDIPINE; PHENOBARBITAL; PRASTERONE SULFATE; QUINIDINE; TESTOSTERONE;

ADOLESCENT; AGE; ARTICLE; CELL CULTURE; CHILD; DEVELOPMENT; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGING; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HYDROXYLATION; INFANT; LIVER; MALE; METHYLATION; OXIDATION-REDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0025161416     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)